ESCMID CHAIR: Dr Stefan Zimmermann • Heidelberg, Germany |
|
16:00 - 16:10 Introduction
16:10 - 16:35 The clinical impact of a routine molecular point-of-care testing strategy in adults presenting to hospital: the results of a large pragmatic randomised controlled trial Dr Tristan Clark • Southampton, UK
16:35 - 17:00 Potentials and challenges of molecular diagnostics in HAP/VAP Pr David Livermore • London, UK
17:00 - 17:25 Value of combined biomarkers and rapid molecular tests in Pediatrics Pr Alain Gervaix • Geneva, Switzerland
17:25 - 17:50 Diagnosing bloodstream infections what’s new? Dr Mark Miller • Marcy l’Étoile, France
17:50 - 18:00 Closing remarks Dr Stefan Zimmermann • Dr Mark Miller |
|
|
Copyright bioMérieux SA